Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Found vs Invyncible

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Found logo

Found

8.3
★★★★4.2/5

Best for: mainstream telehealth GLP-1 access

Visit Found
VS
Invyncible logo

Invyncible

5.8
★★☆☆2.9/5

Best for: corporate-parent-disclosed Florida GLP-1 platform with LegitScript seal

Visit Invyncible

Found and Invyncible are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Found starts at $149/mo, and Found edges ahead overall (8.3 vs 5.8 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

Found

flat price at every doseCompounded
$169$99/mo
Save 41% right now
semaglutide

$169/mo cash-pay on 12-month prepaid plan, medication+membership+coaching included; promo_price 99 = $99/mo WITH insurance (12-mo prepaid). Month-to-month: $199/mo insurance, $289/mo cash. Site-wide '$100 off today' checkout promo running.

flat price at every doseCompounded
$169$99/mo
Save 41% right now
tirzepatide

Same single Compounded GLP-1 Plan price as semaglutide — no per-drug split published (final drug/price assignment is quiz-gated); $169/mo cash 12-mo prepaid ($289/mo month-to-month cash), $99/mo insurance prepaid.

StartingCompounded · oral
$149/mo
orforglipron (foundayo)

'Starting cash price ~$149/mo' on /medication/foundayo comparison table; NEW offering since last verification.

StartingBrand-name
$650/mo
semaglutide (wegovy)

Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.

StartingBrand-name
$650/mo
tirzepatide (zepbound)

Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.

StartingBrand-name
$1100/mo
semaglutide (ozempic)

Homepage carousel 'Ozempic® $1100/mo' — unchanged from prior verification.

StartingBrand-name
$1100/mo
tirzepatide (mounjaro)

Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.

Invyncible

Pricing not publicly listed.

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 390+ providers' prices on their own sites and email you when tracked prices move.

What’s included

Found

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Included

Invyncible

Inclusions not disclosed.

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Found

8.3/10

Overall

Invyncible

5.8/10

Value25%

8.5A
vs
B
5.0

Effectiveness25%

9.0A
vs
B
6.0

User Experience15%

8.0A
vs
B
6.0

Trust & Safety15%

7.3A
vs
B
6.0

Accessibility10%

8.5A
vs
B
6.0

Support10%

7.5A
vs
B
6.4

Features & Coverage

FeatureFoundInvyncible
Starting Price$149/mo
Features3 features6 features
States Available50Not disclosed
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About Found

Personalized weight care platform with a self-pay membership model plus medication costs.

Read our full Found review →

About Invyncible

Invyncible is a Florida-based telehealth platform offering semaglutide and tirzepatide programs for weight management. It openly discloses its corporate parent and physical address — uncommon transparency versus competitors that hide ownership behind a trade name — and displays a LegitScript verification seal. There's no long-term commitment. Pricing tiers aren't published publicly and surface only after the sign-up flow.

Read our full Invyncible review →

Pros & Cons

Found

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

Invyncible

What we like

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Watch-outs

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly
  • No named medical director or clinical leadership
  • FDA compounded-medication disclaimer not published
  • Most content gated behind the signup flow — pricing and drug subpages aren't directly accessible

Our Verdict

Winner: Found

Found edges out Invyncible with a higher overall score of 8.3/10 and is particularly strong for mainstream telehealth GLP-1 access. Invyncible remains a solid alternative, especially if you're looking for corporate-parent-disclosed Florida GLP-1 platform with LegitScript seal.

Choose Found if…

You want mainstream telehealth GLP-1 access and a starting price around $149/mo.

Choose Invyncible if…

You want corporate-parent-disclosed Florida GLP-1 platform with LegitScript seal.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.9

DudeMeds

Men seeking no-fee GLP-1 access with oral and injectable options

7.8

Yucca Health

Mainstream telehealth GLP-1 access

7.7

TrimRx

Best overall value

Found vs Invyncible: FAQ

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring Found and Invyncible head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.